French drugmaker Sanofi will make 30 of its treatments, including insulin, available on a not-for-profit basis in 40 lower-income countries in the first step of its plan to increase access to its medicines worldwide.
https://www.pharmalive.com/wp-content/uploads/2022/04/Sanofi-logo.webp8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-07-04 06:14:302022-07-05 09:31:04Sanofi launches global health brand with non-profit treatments